Edap Tms S.A. (NASDAQ:EDAP) Short Interest Down 34.6% in March

Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 26,300 shares, a decrease of 34.6% from the February 28th total of 40,200 shares. Based on an average daily volume of 75,200 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the shares of the stock are sold short.

Institutional Trading of Edap Tms

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Millennium Management LLC boosted its position in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after purchasing an additional 33,558 shares during the period. BNP Paribas Financial Markets raised its position in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after buying an additional 25,650 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock worth $69,000 after acquiring an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC increased its stake in shares of Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock valued at $355,000 after acquiring an additional 52,500 shares during the period. Finally, Rock Springs Capital Management LP raised its holdings in Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock worth $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Institutional investors own 62.74% of the company's stock.

Edap Tms Trading Down 4.6 %

Shares of NASDAQ EDAP traded down $0.09 during midday trading on Wednesday, reaching $1.87. 266,948 shares of the stock were exchanged, compared to its average volume of 88,632. The stock has a 50 day moving average price of $2.41 and a 200-day moving average price of $2.48. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $69.38 million, a P/E ratio of -2.88 and a beta of 0.37. Edap Tms has a 52-week low of $1.86 and a 52-week high of $8.50.

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on EDAP. HC Wainwright reissued a "buy" rating and set a $19.00 price objective on shares of Edap Tms in a research note on Friday, March 28th. StockNews.com assumed coverage on Edap Tms in a research report on Friday, March 28th. They set a "hold" rating for the company. Finally, Piper Sandler cut their price target on Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a report on Friday, March 28th.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.